Wip1 Phosphatase Involved in Lipopolysaccharide-Induced Neuroinflammation

被引:15
|
作者
Tan, Xiang [1 ]
Zhang, Jingjing [1 ]
Jin, Wei [1 ]
Li, Lei [1 ]
Xu, Wei [1 ]
Zheng, Heyi [1 ]
Rui, Ying [1 ]
Ke, Kaifu [1 ]
Zhou, Ranran [2 ]
Cao, Maohong [1 ]
Pan, Yongjin [1 ]
机构
[1] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China
[2] Nantong Univ, Affiliated Hosp, Dept Endocrinol, Nantong 226001, Jiangsu, Peoples R China
关键词
Wip1; Lipopolysaccharide; Neuroinflammation; Astrocyte; Rat; NF-KAPPA-B; PARKINSONS-DISEASE; REGULATOR; PATHWAYS; NEUROPROTECTION; ACTIVATION; MICROGLIA; RADIATION; MAPK; MICE;
D O I
10.1007/s12031-013-0080-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Wild type p53-induced phosphatase 1 (Wip1) is a phosphatase which belongs to protein phosphatase type 2C family, which have been predominantly linked to cell growth and to cellular stress signaling. Numerous downstream targets of Wip1 have been identified, and genetic studies confirm that some play a part in tumorigenesis. Recent evidence highlights a new role for Wip1 in the regulation of NF-kappa B p65, which indicated that it might play a critical role in immune system. However, its regulation role in central nervous system (CNS) remains poorly understood. To elaborate whether Wip1 was involved in CNS injury, we performed a neuroinflammatory model by lipopolysaccharide (LPS) lateral-ventral injection in adult rats. Wip1 expression was strongly upregulated in active astrocytes in inflamed brain cortex. In vitro studies indicated that the upregulation of Wip1 may be involved in the subsequent astrocytic activation following LPS exposure, and knockdown of Wip1 in primary astrocytes by siRNA showed that Wip1 inhibited the synthesis of TNF-alpha. Collectively, these results suggested that Wip1 may be important in host defense in CNS immune response, which might provide a potent therapeutic target of neuroinflammation.
引用
收藏
页码:959 / 966
页数:8
相关论文
共 50 条
  • [41] Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction
    Gilmartin, Aidan G.
    Faitg, Thomas H.
    Richter, Mark
    Groy, Arthur
    Seefeld, Mark A.
    Darcy, Michael G.
    Peng, Xin
    Federowicz, Kelly
    Yang, Jingsong
    Zhang, Shu-Yun
    Minthorn, Elisabeth
    Jaworski, Jon-Paul
    Schaber, Michael
    Martens, Stan
    McNulty, Dean E.
    Sinnamon, Robert H.
    Zhang, Hong
    Kirkpatrick, Robert B.
    Nevins, Neysa
    Cui, Guanglei
    Pietrak, Beth
    Diaz, Elsie
    Jones, Amber
    Brandt, Martin
    Schwartz, Benjamin
    Heerding, Dirk A.
    Kumar, Rakesh
    NATURE CHEMICAL BIOLOGY, 2014, 10 (03) : 181 - +
  • [42] Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase
    H Fujimoto
    N Onishi
    N Kato
    M Takekawa
    X Z Xu
    A Kosugi
    T Kondo
    M Imamura
    I Oishi
    A Yoda
    Y Minami
    Cell Death & Differentiation, 2006, 13 : 1170 - 1180
  • [43] Wip1 phosphatase: between p53 and MAPK kinases pathways
    Goloudina, Anastasia R.
    Kochetkova, Elena Y.
    Pospelova, Tatyana V.
    Demidov, Oleg N.
    ONCOTARGET, 2016, 7 (21) : 31563 - 31571
  • [44] Substrate specificity of the human protein phosphatase 2Cδ Wip1
    Yamaguchi, H
    Minopoli, G
    Demidov, ON
    Chatterjee, DK
    Anderson, CW
    Durell, SR
    Appella, E
    BIOCHEMISTRY, 2005, 44 (14) : 5285 - 5294
  • [45] NF-kappaB is a novel transcriptional regulator of the oncogenic Wip1 phosphatase
    Lowe, Julie
    Yang, Qian
    Cha, Hyukjin
    Fornace, Albert
    CANCER RESEARCH, 2009, 69
  • [46] Remimazolam attenuates lipopolysaccharide-induced neuroinflammation and cognitive dysfunction
    Zhou, Leguang
    Shi, Hongzhao
    Xiao, Mengzhe
    Liu, Wenjie
    Wang, Lijuan
    Zhou, Shangtao
    Chen, Shenghua
    Wang, Yan
    Liu, Chengxi
    BEHAVIOURAL BRAIN RESEARCH, 2025, 476
  • [47] Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase
    Fujimoto, H.
    Onishi, N.
    Kato, N.
    Takekawa, M.
    Xu, X. Z.
    Kosugi, A.
    Kondo, T.
    Imamura, M.
    Oishi, I.
    Yoda, A.
    Minami, Y.
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (07): : 1170 - 1180
  • [48] Targeting WIP1 phosphatase promotes partial remission in experimental collapsing glomerulopathy
    Duret, Lou C.
    Hamidouche, Tynhinane
    Steers, Nicholas J.
    Pons, Catherine
    Soubeiran, Nicolas
    Buret, Delphine
    Gilson, Eric
    Gharavi, Ali G.
    D'Agati, Vivette D.
    Shkreli, Marina
    KIDNEY INTERNATIONAL, 2024, 105 (05) : 980 - 996
  • [49] Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction
    Gilmartin A.G.
    Faitg T.H.
    Richter M.
    Groy A.
    Seefeld M.A.
    Darcy M.G.
    Peng X.
    Federowicz K.
    Yang J.
    Zhang S.-Y.
    Minthorn E.
    Jaworski J.-P.
    Schaber M.
    Martens S.
    McNulty D.E.
    Sinnamon R.H.
    Zhang H.
    Kirkpatrick R.B.
    Nevins N.
    Cui G.
    Pietrak B.
    Diaz E.
    Jones A.
    Brandt M.
    Schwartz B.
    Heerding D.A.
    Kumar R.
    Nature Chemical Biology, 2014, 10 (3) : 181 - 187
  • [50] Phosphatase WIP1 regulates adult neurogenesis and WNT signaling during aging
    Zhu, Yunhua
    Demidov, Oleg N.
    Goh, Amanda M.
    Virshup, David M.
    Lane, David P.
    Bulavin, Dmitry V.
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (07): : 3263 - 3273